The US approves the use of Regeneron’s treatment against Covid-19 – World

Washington. The United States granted emergency approval on Saturday for a treatment with synthetic antibodies against Covid-19 from the company Regeneron that was used to treat President Donald Trump when he contracted the coronavirus.

“Licensing these monoclonal antibody therapies can help outpatients avoid being hospitalized and ease the burden on our healthcare system,” said Stephen Hahn, Commissioner of the US Food and Drug Administration (FDA).


Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.